Donate

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Isatuximab

Isatuximab (December 2019)

Isatuximab is a new drug that is being investigated for the treatment of myeloma. This factsheet describes briefly what it is, how it works, how it is given, the possible benefits over existing drugs, the possible side-effects, and its availability in the UK.

Author(s)
Myeloma UK
Place of publication
Edinburgh
Publisher
Myeloma UK
Date of publication
December 2019
Pages
8pp
Series
Horizons Infosheet. Clinical trials and novel drugs
Supplier
https://www.myeloma.org.uk
Subject(s)
Myeloma, Monoclonal antibodies, Isatuximab
Format
Factsheet
Language
English
Flesch readability score
32.4
Download this resource
Download this resource
Back to results
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Donate

About this site

Macmillan sites

Right there with you

We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you. Contact us

Follow us

© Macmillan Cancer Support 2019 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007